Skip to main content
. 2022 Sep 26;24(5):691. doi: 10.3892/etm.2022.11627

Table II.

Baseline risk factors associated with acute hepatitis during hospital stay in 1,304 patients with COVID-19 infection (univariate and multivariate analysis).

  Univariate analysis Multivariate analysis
Variables Hazard ratio P-value 95% Confidence interval Lower limit 95% Confidence interval Upper limit Hazard ratio P-value 95% Confidence interval Lower limit 95% Confidence interval Upper limit
Age, years 0.99 0.61 0.97 1.054        
Sex, male 0.89 0.75 0.45 1.72        
Co-morbidities                
     Diabetes mellitus 1.36 0.44 0.62 2.99        
     Severe (class II) obesity (BMI ≥35 kg/m²) 1.42 0.56 0.43 4.71        
     Arterial hypertension 1.31 0.47 0.63 2.68        
     Gastrointestinal symptoms 1.97 0.17 0.74 5.33        
AST (IU/l) 1.008 <0.001 1.006 1.009 1.008 <0.001 1.006 1.011
ALT (IU/l) 1.007 <0.001 1.006 1.009        
ALP (IU/l) 1.002 0.51 0.99 1.006        
γ-GT (IU/l) 1.002 0.19 0.99 1.005        
Total bilirubin (mg/dl) 0.99 0.34 0.908 1.095        
LDH (IU/l) 1.002 <0.001 1.001 1.003        
Albumin (g/dl) 0.99 0.64 0.97 1.017        
CRP (mg/l) 1.00 0.81 0.99 1.001        
INR 0.98 0.85 0.85 1.10        
D-Dimers (mg/dl) 1.00 0.99 0.99 1.001        
Fibrinogen (mg/dl) 1.001 0.27 0.99 1.003        
Ferritin (ng/ml) 1.003 0.007 1.001 1.004        
WBC (x109/l) 0.99 0.85 0.93 1.06        
PLTs (x109/l) 0.99 0.26 0.99 1.002        
HBsAg (+) or anti-HCV (+) 4.05 0.026 1.18 13.9        
COVID-19 medication                
     Remdesivir 0.41 0.025 0.19 0.89        
     Dexamethasone 1.21 0.76 0.36 3.98        
     Tocilizumab 1.98 0.09 0.88 4.47        

AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; γ-GT, γ-glutamyl transpeptidase; LDH, lactate dehydrogenase; INR, international normalized ratio; CRP, C-reactive protein; WBC, white blood count; PLTs, platelets; BMI: body mass index.